Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

(2020) Hussin A. Rothan et al.   JOURNAL OF AUTOIMMUNITY

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A new coronavirus associated with human respiratory disease in China

(2020) Fan Wu et al.   NATURE

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

(2020) Enli Liu et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic?

(2020) Mayda Gursel et al.   ALLERGY

Is BCG vaccination affecting the spread and severity of COVID‐19?

(2020) Cevdet Ozdemir et al.   ALLERGY

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

NKG2A and COVID-19: another brick in the wall

(2020) Luca Antonioli et al.   Cellular & Molecular Immunology

Pathogenesis of COVID-19 from a cell biology perspective

(2020) Robert J. Mason   EUROPEAN RESPIRATORY JOURNAL

The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection

(2020) Sanjeeth Rajaram et al.   IMMUNITY

Acute transverse myelitis after COVID-19 pneumonia

(2020) Maike Munz et al.   JOURNAL OF NEUROLOGY

Considering BCG vaccination to reduce the impact of COVID-19

(2020) Nigel Curtis et al.   LANCET

Development of an inactivated vaccine candidate for SARS-CoV-2

(2020) Qiang Gao et al.   SCIENCE

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2

(2020) Jianzhong Shi et al.   SCIENCE

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

(2020) Barry Rockx et al.   SCIENCE

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Bo Diao et al.   Frontiers in Immunology

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

(2020) Jing Liu et al.   EBioMedicine

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

(2020) Wen Wen et al.   Cell Discovery

Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents

(2020) Ahmed Yaqinuddin et al.   MEDICAL HYPOTHESES

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury

(2019) Takahiro Uchida et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma

(2019) Jian Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases

(2019) Gildas Lepennetier et al.   Journal of Neuroinflammation

Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering

(2018) May Daher et al.   CURRENT OPINION IN IMMUNOLOGY

Nonhuman Primate Models of Respiratory Disease: Past, Present, and Future

(2017) Lisa A Miller et al.   ILAR JOURNAL

Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69 − CD56 dim cells

(2017) Nicole Marquardt et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Engineering Natural Killer Cells for Cancer Immunotherapy

(2017) Katayoun Rezvani et al.   MOLECULAR THERAPY

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

(2016) Shuo Su et al.   TRENDS IN MICROBIOLOGY

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis

(2016) Catharina C. Gross et al.   Frontiers in Immunology

Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy

(2015) Mirelle J.A.J. Huijskens et al.   CYTOTHERAPY

Rapid generation of a mouse model for Middle East respiratory syndrome

(2014) Jincun Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus

(2014) Fumihiko Yasui et al.   VIROLOGY

NK cells exacerbate the pathology of influenza virus infection in mice

(2013) Gang Zhou et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition

(2013) Thomas Perlot et al.   MICROBES AND INFECTION

Pneumonia from Human Coronavirus in a Macaque Model

(2013) Vincent J. Munster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lung natural killer cells in mice: phenotype and response to respiratory infection

(2012) Jian Wang et al.   IMMUNOLOGY

IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection

(2012) P Kumar et al.   Mucosal Immunology

IL-6 plays an essential role in neutrophilia under inflammation

(2011) Misato Hashizume et al.   CYTOKINE

Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection

(2011) Bisweswar Nandi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection

(2009) J. Chen et al.   JOURNAL OF VIROLOGY

Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2

(2008) J. Netland et al.   JOURNAL OF VIROLOGY